Search results :

Acetaminophen

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: N02BE01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Injection site pain 2% - 14.7% x x x x
Nervous system disorder very rare, 9.7% 8.71% x x x x x x x x
Injection site reaction 2.67% - 14.7% x x x
Mental disorder 7.46% 5.54% x x x x x x
Insomnia 7.46% 1.96% - 5.54% x x x x x x x x
Constipation 6.7% 11.8% x x x x x x x x
Headache 1.3% - 9.7% 4.9% - 8.71% x x
Drowsiness common x x x x
Dry mouth common x x x x x x
Disturbance in attention common x x
Unsteadiness common x
Vomiting postmarketing, 4% - 5.26% 2.9% x x x x x x x x x
Anaemia 2.7% 6.9% x x x x
Dizziness common, 2.7% 2.9% x x x x x x x x x x
Cough 2% x x x
Postoperative hemorrhage 2% x
Enlargement abdomen 2% x x x
Fatigue common, 1.59% x x x x x x x
Chest pain 1.33% x x x
Diarrhoea 1.3% x x x x x
Dyspepsia 1.3% x
Hyperglycaemia 1.3% x x x
Hypokalaemia 1.3% x x x x
Alveolitis 1.3% 2.94% x x x
Body temperature increased 1.05% - 5.47% 5.9% - 13.7% x x x x
Hypotonia 1.05% x x x
Nausea postmarketing, 1.05% - 10% 8.8% x x x x x x x x x x x
Gastrointestinal disorder postmarketing — 2% x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x x x
Bladder neck obstruction postmarketing x x x
Dermatitis atopic postmarketing x x x x
Dysuria postmarketing x x x
Oedema postmarketing x x x
Rash postmarketing x x x x x x x x x x x x x x x x
Eye disorder postmarketing — common x x x
Flushing postmarketing x x x
Angle closure glaucoma postmarketing x x x
Cardiac disorder postmarketing, rare x x x x x x x x
Hypersensitivity postmarketing x x x x x x x x x x x x
Mydriasis postmarketing x x x
Palpitations postmarketing x x x x
Pruritus postmarketing, 3.3% 4.9% x x x x x
Tachycardia postmarketing x x x x x x x
Thrombocytopenia postmarketing x x x x x x x x x x x x x x x
Erythema postmarketing x x x
Urinary tract disorder postmarketing, rare x x x x x
Urticaria postmarketing x x x x x x x
Urinary retention postmarketing x x x x
Hepatic failure postmarketing x x x
Hepatic necrosis postmarketing x x x
Acute angle-closure glaucoma postmarketing x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x
Hepatic enzyme increased postmarketing x x x
Hepatitis fulminant postmarketing x x x
Administration site reaction postmarketing x x x
Prostatic hypertrophy postmarketing x x x
Immune system disorder very rare, postmarketing x x x x x x x x x x x x
Mediastinal disorder very rare x x x x x x x x x x
Hepatobiliary disease very rare, postmarketing x x x x x x x x x x x
Blood and lymphatic system disorders very rare x x x x x x x x x x
Abdominal pain x x x x x x
Pancreatitis acute x
Agranulocytosis x x x x x x
Haemolytic anaemia x x
Angioedema x x x x x x x x
Anorexia x
Anxiety x x x x
Asthma x
Atelectasis x
Bronchospasm x x x x x x x x x x
Coma x x
Confusional state x x
Connective tissue disorder x x x
Dermatitis exfoliative x
Dyskinesia x
Dyspnoea x x x x
Toxic epidermal necrolysis x x x
Eructation x x x
Hallucination x
Blood disorder x
Haemorrhage x x
Hypertension x x
Hypotension x x x x x
Irritability x x
Renal failure acute x x
Nephrosis lower nephron x
Leukopenia x x
Myoclonus x
Nervousness x x x x x
Neutropenia x x x
Nightmare x
Oliguria x
Pain in extremity x
Pancytopenia x x
Pleural effusion x
Pulmonary oedema x
Convulsion x
Shivering x
Shock x x
Muscle spasms x
Stevens-Johnson syndrome x x x x x x x x x
Stridor x
Sweating x
Tremor x
Trismus x
Uremia x
Angiopathy x x
Wheezing x
Agitation x x x x x
Rash pustular x x
Oedema peripheral x x x x
Hypophosphataemia x
Hepatic function abnormal x x x x x x x x
Periorbital oedema x
Hypomagnesaemia x
Hepatocellular injury x
Muscular weakness x
Hyperreflexia x
Aspartate aminotransferase increased x
Urinary hesitation x
Liver injury x
Malnutrition x x
Acute hepatic failure x
Lightheadedness x
Rash macular x x
Fixed drug eruption x
Malaise x x
Muscle twitching x x
Breath sounds abnormal x
Chest tightness x x
Digestion impaired x x x
Abdominal discomfort x
Dysphoria x
Respiratory depression x
Euphoric mood x
Pemphigoid reaction x x
Hypoalbuminaemia x
Strangury x
Vision blurred x x
Photosensitivity x
Rash maculo-papular x x
Energy increased x x
Blood pressure increased x x x
Coordination abnormal x
Dystonic reaction x
Fluid overload x
Cutaneous hypersensitivity x x x x x x x x x
Drug interaction x
Serotonin syndrome x
Sweating increased x
Mental status changes x
Acute generalised exanthematous pustulosis x
Anaemia postoperative x
Cytolytic hepatitis x
Infusion site pain x
Kounis syndrome x
Somnolence x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Paracetamol / PANAMAX

Side effects:24
Source:medicines.org.au

ACETAMINOPHEN

Side effects:16
Source:FDA Structured Product Label

acetaminophen

Side effects:51
Source:FDA Structured Product Label

Paracetamol / PERFALGAN

Side effects:58
Source:medicines.org.au

PANADOL Night Tablets / Panadol Night, Tablet

Side effects:39
Source:Medsafe

DESCRIPTION / PANADOL EXTRA

Side effects:18
Source:medicines.org.au

DESCRIPTION / Panadeine Extra

Side effects:21
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label